Free Trial
→ The $15 Gold Fund That Pays Up to $1,152/Month (From Investors Alley) (Ad)tc pixel
NASDAQ:YI

111 Q1 2025 Earnings Results & Report

111 logo
$3.09 -0.02 (-0.64%)
Closing price 03:59 PM Eastern
Extended Trading
$3.08 -0.01 (-0.29%)
As of 06:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

111 reported Q1 2025 earnings on June 19, 2025. The company reported EPS of -$0.20, while revenue was $486.35 million.

Research:ProfileEarnings HistoryForecast

Earnings Announcement Details

Quarter
Q1 2025
Report Date
Time
Before Market Opens
Conference Call Date
Conference Call
12:00 AM ET

111 EPS Results

Actual EPS
-$0.20
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

111 Revenue Results

Actual Revenue
$486.35 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Upcoming Earnings

111's Q3 2026 earnings is estimated for Thursday, November 26, 2026, based on past reporting schedules

Conference Call Resources

Powered by Quartr

Earnings Documents

111's Q1 2025 Press ReleasePress Release
(8-K)

111 Q1 2025 Earnings FAQ

111 (NASDAQ:YI) reported earnings of -$0.20 per share for Q1 2025. The report was announced on Thursday, June 19, 2025.

111 reported revenue of $486.35 million for Q1 2025.

111's next earnings date is estimated for Thursday, November 26, 2026. MarketBeat tracks confirmed and estimated earnings dates for 111 on the company's earnings history page.

111 Earnings Headlines

Critical Contrast: Tempus AI (NASDAQ:TEM) and 111 (NASDAQ:YI)
October 11, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31107789
111, Inc. Announces Establishment of Special Committee
September 28, 2026  |  marketscreener.comM
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.tc pixel
October 15 at 1:00 AM  |  InvestorPlace (Ad)
111 Forms Special Committee To Review Takeover Proposal And Strategic Options
September 28, 2026  |  rttnews.comhttps://www.rttnews.com/3694256/111-forms-special-committee-to-review-takeover-proposal-and-strategic-options.aspx
111, Inc. Announces Establishment of the Special Committee
September 28, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/111-inc-announces-establishment-of-the-special-committee-302891226.html
111, Inc Q2 Loss Widens From Lower Revenue; Shares Up
September 17, 2026  |  rttnews.comhttps://www.rttnews.com/3692015/111-inc-q2-loss-widens-from-lower-revenue-shares-up.aspx
See More 111 Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like 111? Sign up for Earnings360's daily newsletter to receive timely earnings updates on 111 and other key companies, straight to your email.

About 111

111 (NASDAQ:YI), Inc. (NASDAQ: YI) is a China-based technology-enabled healthcare platform that connects consumers, healthcare providers, pharmacies and pharmaceutical companies. The company focuses on improving access to healthcare products and services through digital tools and an integrated online and offline operating model.

Its business activities include online retailing and distribution of prescription and over-the-counter medicines, health products, medical devices and other healthcare-related goods. Through its digital platforms, 111 also provides medication information, health-management resources and other services intended to support consumers and healthcare professionals.

111 serves customers and business partners primarily in China. The company was founded in 2010 and has developed operations spanning consumer healthcare, pharmaceutical distribution and technology services. Its platforms are designed to connect pharmaceutical manufacturers with hospitals, pharmacies, clinics and individual consumers across the Chinese healthcare market.

111, Inc. was co-founded by Junling Liu, who has served as the company’s chief executive officer. The company completed its initial public offering on the Nasdaq Stock Market in 2018.

View 111 Profile
Earnings Tools